OURLYRA

Trademark usage description

pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for autoimmune diseases and immunologic deficiency syndromes; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of kidney diseases and disorders.

Classification kind code

Mark Details

Serial Number

2331217

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 231 on 13^th Feb 2025	Limitation
Submitted for opposition 48 on 18^th Jul 2024	Agent Changed
Submitted for opposition 257 on 6^th Jun 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 5^th Jun 2024	Created
Submitted for opposition 31 on 5^th Jun 2024	Formalized
Submitted for opposition 30 on 28^th Mar 2024	Filed
Submitted for opposition 228 on 28^th Mar 2024	International Registration